Trastuzumab Recruiting Phase 3 Trials for HER2 Positive Breast Cancers / Stage I Breast Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01785420Pre Operative Trastuzumab in Operable Breast Cancer
NCT03493854A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer